Calcium
PreclinicalSmall molecule
Eli LillyCalcium is a mineral that your body needs for strong bones and teeth, and it also helps your muscles and nerves work properly. It's used to treat or prevent calcium deficiency and to support bone health.[1] Calcium is currently being investigated across 9 indications[3], with its most advanced program in Preclinical.[1]
Calcium is one of 178 small molecule programs targeting Systemic Lupus Erythematosus. It is currently in Preclinical.
9
Indications
27
Total Trials
3
Active Trials
177
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
309 competitors in COVID-19
#DrugCompanyPhaseTrials
1Stivarga
BayerPreclinical
Aimovig
AmgenPreclinical
Aldactone
PfizerPreclinical
Nexavar
BayerPreclinical
Calcium
Eli LillyPreclinical
Calciferol
Jazz PharmaceuticalsPreclinical
Activella
Eli LillyPreclinical
Angiomax
BBaxter Healthcare Corporation
Preclinical
Tricor
JJagotec
Preclinical
Precedex
MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Treatment2 trials
Musculoskeletal1 trial
20 more indications
Hypoparathyroidism1 trial
Osteoporosis1 trial
Ovarian Hyperstimulation Syndrome1 trial
Calcium for Prevention of Ovarian Hyperstimulation Syndrome
Completed·—·Phase 3·NCT01427335·200 enrolled
Oxytocin1 trial
Atrial Fibrillation1 trial
Colorectal Cancer1 trial
Study of Folic Acid, Calcium and Vitamin D in Preventing Colorectal Polyps and Colorectal Cancer
Unknown status·SShanghai Jiao Tong University School of Medicine·Phase 2/3·NCT02066688·2,400 enrolled
Hypocalcemia1 trial
Cirrhosis1 trial
Dense Breasts1 trial
Breast Cancer1 trial
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Calcium. EMBL-EBI & Wellcome Sanger Institute.
- [4]